Skip to content

News

Merger to bolster jet fuel consumption

The restructuring of Sinopec and CNAF was announced by the State-owned Assets Supervision and Administration Commission of the State Council on Thursday. [Photo/VCG] China has greenlit a landmark merger between its top refiner China Petroleum and Chemical Corp (Sinopec) and China National Aviation Fuel Group, creating a vertically integrated giant to anchor a market where…

HK sees innovation, tech efforts bear fruit

HONG KONG — From the first homegrown chip to the rapid rise in global innovation rankings, Hong Kong has accelerated its pivot toward innovation and technology (I&T) over the past year, positioning the sector as a critical new engine for growth alongside its traditional economic pillars. In November, Hong Kong debuted the Lion Rock chip,…

Airbus lands large-scale year-end aircraft orders from Chinese carriers

An A320 aircraft is assembled at Airbus’ second final assembly line in Tianjin on Oct 22. TONG YU/CHINA NEWS SERVICE Airbus secured a flurry of year-end aircraft orders from Chinese airlines, reinforcing the European planemaker’s dominance in China and its long-term commitment to the world’s second-largest aviation market. In just two days at the end…

Upgrades to encourage spending

With the imbalance between strong supply and lukewarm domestic demand still existing, China’s renewed push for large-scale equipment upgrades in 2026 is expected to reinforce domestic demand, stimulate productive investment and advance greener, smarter industrial upgrading, thereby adding fresh momentum to consumption and broader economic growth, experts said. The country will broaden its equipment renewal…

Pricing deal to avoid EU tariffs on Chinese EVs

Visitors explore the XPeng booth on Saturday at the Brussels Motor Show in Belgium. Chinese electric vehicle brands are among the highlights of the show, which runs from Jan 9 to 18. PENG ZIYANG / XINHUA China and the European Union, after more than a year of talks, have agreed to set minimum prices for…

Zhuzhou pharm company signs huge licensing deal

Biopharmaceutical company Zonsen PepLib Biotech said in a company statement on Monday that it has struck a global licensing deal with Swiss multinational pharmaceutical company Novartis to develop a new peptide-based treatment, netting an upfront payment of $50 million. The agreement focuses on an undisclosed asset used in radioligand therapy, a precision cancer treatment that delivers…